T1	p 79 116	acute invasive diarrhea in children .
T2	p 369 442	acute invasive diarrhea requiring an emergency visit in southern Israel .
T3	p 699 748	acute invasive diarrhea in infants and children .
T4	p 770 964	From July 1996 through December 1997 , 201 evaluable children ages 6 months to 10 years ( 35 % < 1 year ; 70 % < 3 years ) presenting with acute invasive diarrhea at the Pediatric Emergency Room
T5	p 1430 1472	127 pathogens from 121 ( 60 % ) patients :
T6	p 2396 2488	acute invasive diarrhea in ambulatory pediatric patients requiring an emergency room visit .
T7	i 6 54	Oral ciprofloxacin vs. intramuscular ceftriaxone
T8	i 281 320	antibiotics , intramuscular ceftriaxone
T9	i 999 1059	ciprofloxacin suspension ( 10 mg/kg twice a day + im placebo
T10	i 1074 1113	im ceftriaxone ( 50 mg/kg/day + placebo
T11	i 1803 1832	ciprofloxacin and ceftriaxone
T12	i 2293 2311	Oral ciprofloxacin
T13	i 2355 2366	ceftriaxone
T14	o 79 102	acute invasive diarrhea
T15	o 614 633	efficacy and safety
T16	o 699 722	acute invasive diarrhea
T17	o 915 932	invasive diarrhea
T18	o 1325 1353	Clinical response and safety
T19	o 1738 1766	Clinical cure or improvement
T20	o 2056 2083	drug-related adverse events
T21	o 2396 2419	acute invasive diarrhea